Save the date for “What Does High Factor Activity Mean to You? – Pharmacokinetics and Factor Activity Level in Hemophilia B, a Dinner Talk hosted by Novo Nordisk on Wednesday, December 7 at 6p.
This program describes pharmacokinetic concepts and the importance of knowing the half-life of your factor product and how it affects your factor activity level over time. The second part of the program presents the safety and efficacy of Rebinyn®, as well as its key product attributes such as pharmacokinetics.
Speaker: Jonathan C. Roberts, MD, Associate Medical Director and Associate Research Director at the Bleeding & Clotting Disorders Institute and Assistant Professor of Pediatrics at the University of Illinois College of Medicine at Peoria
HFM will treat attendees to dinner during this educational program.
Please note, Novo Nordisk is not affiliated with the meals provided by HFM. Order carryout or delivery and send a photo of your itemized receipt to Laura at email@example.com. You will be reimbursed for your meal (up to $30 per family). Please note that we are unable to reimburse alcohol purchases.
HFM does not endorse any specific product or company.